Moderna’s bivalent covid-19 vaccine—which targets both the original version of SARS-CoV-2 and the omicron BA.1 variant—will be rolled out alongside the original Moderna, Pfizer, and Novavax covid-19 vaccines, the Joint Committee on Vaccination and Immunisation (JCVI) has said.
Entire content available on: https://www.bmj.com/content/378/bmj.o2038
Language
EnglishTypology
News and updatesTopic
Covid-19 Vaccine PreparednessTarget
Public HealthCountries
Europe & UK